Acceptance of a Malaria Vaccine by Caregivers of Sick Children in Kenya Amref Health in Africa International Conference 24th – 26th October, Nairobi, Kenya Sarah Karanja1,David Ojakaa2, Jordan Jarvis3, Mary Matilu4 and Sylla Thiam5 1.AMREF Kenya 2.Formerly with AMREF Kenya 3.AMREF Canada 4.KEMRI 5.Amref Health in Africa Headquarters Overview of Presentation • • • • • • • Introduction Background Study objectives Methods Variables captured Results Conclusion and recommendations Introduction • Malaria a life threatening parasitic disease • About 70% of Kenyan population at risk (NMCP) • Kenyan response is broad - four pronged • Nevertheless KMIS 2010 shows gaps persist: – ITN coverage is one net for five people – 25% of expectant women received IPT at ANC • Malaria vaccine – close gap left by these interventions Background • Several malaria vaccines are currently in clinical trials. • GSK’s RTS,S is currently in Phase 3 clinical development • Consider sociocultural environment of region for widespread approval. • In 2010 AMREF conducted this study on behalf of PATH Malaria Vaccine Initiative Study Objectives • General: To analyse and share complimentary information on attitudes of individuals in Kenya towards a possible malaria vaccine • Specific: Determine attitudes of caregivers towards a malaria vaccine Identify key factors influencing attitudes of caregivers Methods • Exit interviews with 2003 caregivers in 695 health facilities across Kenya during the 2010 KSPA • Descriptive statistics (cross-tabulation) and multinomial regression were used to analyze the determinants of accepting a child to be immunized with the malaria vaccine. List of Variables for Analysis • Facility /Community– level factors: – Facility type; Operating authority; Fees for services?; Opinion on services • Sick child – characteristics – Type of visit; Diagnosis for malaria; Taking malaria drug; Problems causing visit • Caregiver – characteristics – Opinion of services received; Relationship to the sick child; Socio-demographic characteristics • Malaria vaccine questions – Whether would accept young child in community or own child getting the malaria vaccine. Characteristics of Caregivers Characteristics of respondents Sex Female Male Age <20 20-34 35-49 50+ Relationship to child Mother Father Other Per cent 93.5 6.5 8.2 76.6 13.6 1.6 90.3 5.9 3.8 Characteristics of Sick Children Characteristic Sex Female Male Age (years) <1 1-2 2-3 3-4 4-5 Malaria diagnosis (clinical) Yes No Malaria test (blood smear or rapid test) Percentage Positive Negative 16.1 83.9 53 47 33.7 30 17.2 11.6 7.5 38.1 61.9 Acceptance of Child Vaccination Child in community Own child % % Yes 88.7 88.0 No 4.6 4.6 Don’t know 6.7 7.4 Caregivers educational factor and acceptance of vaccine Factors Vaccination in Vaccination of own community child Yes No Don't Yes No Don't know know % Ever attended school Yes (85.9%) No (14.1%) Literacy Read and write (64%) Read only (4.08%) None (32%) 94 56 3 13 3 31 93 55 4 7 3 38 96 2 2 95 3 2 74 69 6 9 20 22 71 69 8 5 21 26 Approval of Vaccine by Region Region Nyanza Coast Eastern Central Western Rift Valley Nairobi North Eastern Approval of Vaccine (%) 98.9 98.7 97.8 96.7 95.4 91 87 23 Factors associated with acceptance of malaria vaccine Variable RRR P-value Central 4.0 ** Coast 13.1 *** Eastern 8.7 *** North Eastern 0.3 * Nyanza 12.0 *** Rift Valley 3.2 ** Western 3.7 ** 0.5 ** 35-49 0.3 * 50+ 0.1 * 0.4 * Region: Satisfaction with health services: Somewhat Age of Caretaker: Ever Attended school No *** p<0.001 **p<0.01 *p<0.05 Conclusion and recommendations • The results show high endorsement and expectations of the vaccine, except for North Eastern Province. • This calls for the need to carefully manage the expectations as the vaccine is released • Target specific segments of child caregivers with relevant messages and education on the malaria vaccine • Target audiences include residents where acceptance is low; older caregivers and those with low literacy levels; service providers Acknowledgements • PATH MVI: for funding • National Council for Population and Development (NCPD) for coordination of KSPA • Division of Vaccines and Immunization: Advice on priority research questions • Division of Malaria Control: Support • ICF Macro: Providing the datasets • AMREF: Technical/Administrative Support THANK YOU